Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Sunday, March 26, 2023.

Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)

Strong Downtrend (-100) - CNCR is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, CNCR continues to fall. Traders should use caution and set stops.

Is it time to buy, sell, or avoid CNCR?

MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

Open High Low CNCR Price Change
11.8600 11.9433 11.6800 11.6800 -0.1051
Entry Signal

MarketClub’s Trade Triangles for CNCR

long term down The long-term trend has been DOWN since Dec 19th, 2022 at 13.98

intermediate term down The intermediate-term trend has been DOWN since Feb 13th, 2023 at 14.45

short term down The short-term trend has been DOWN since Feb 7th, 2023 at 14.95

Smart Scan Analysis for CNCR

Based on our trend formula, CNCR is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Smart Scan Analysis for CNCR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
11.8600 11.9433 11.6800 11.6800 -0.1051
Prev. Close Volume Bid Ask Time
11.8600 5964 2023-03-23 14:02:19
Year High32.32Year High Date2018-03-13
Year Low19.1252Year Low Date2018-10-29
52wk High19.356552wk High Date2022-04-05
52wk Low11.6852wk Low Date2023-03-23
Average Volume2,884Shares Outstanding100
Market Cap34MVolatility39.81
Get a free daily analysis and signals for Loncar Cancer Immunotherapy ETF (CNCR) - Request Your Free Report.